US: Partnership to Develop Animated Simulations of the Aging Eye

Partager cet article

Ophthalmic device manufacturer, Refractec, Inc. is teaming up with interactive design and multimedia development firm, Eyemaginations, Inc. to create a specialized presbyopia patient education animation program for distribution to more than 800 ophthalmologists across the U.S. ; The Eyemaginations’ product will be available for sale and distribution beginning in January 2006.


;


The custom production will feature 3D animations simulating presbyopia, the leading eye condition among Baby Boomers in the U.S., and Refractec’s NearVision CK (conductive keratoplasty), the only non-laser treatment for near vision loss associated with presbyopia (a.k.a. « aging eyes »). ; The PC-based patient education package will be available for use in waiting rooms, exam rooms and consultation areas.


;


« This educational program will help make ophthalmic consultations more productive for both patients and physicians, » said Tom Frinzi, Refractec’s chief operating officer. ; « The Eyemaginations package will be a powerful communication tool for physicians to help explain the presbyopic condition and the value of NearVision CK as a treatment option. »


;


In addition to detailed overviews and simulations of presbyopia and the NearVision CK treatment, the program will offer physicians the ability to update into the Eyemaginations 3D-Eye Office full software suite allowing physicians to add hundreds of other exciting 3D animations including their own video segments.


;


« We specialize in creating compelling visual programming and educational elements for the eye-care industry, » said Jeff Peres, Eyemaginations’ chief executive officer. ; « Refractec’s project will showcase our capabilities and give more than 800 doctors a chance to see how our products enhance their refractive practice. »


;


In 2004, Refractec’s NearVision CK became the leading nonlaser refractive treatment in the U.S. and is the fastest growing vision procedure since the introduction of LASIK. ; To date, more than 125,000 CK treatments have been performed worldwide with more than 800 physicians certified to perform NearVision CK.


;


About Eyemaginations, Inc.


Founded in 1999, Eyemaginations, Inc. is a full-service interactive design and multimedia development firm for the eye-care industry. ; Their in-depth experience with 3D design, software development and technology deployment has allowed Eyemaginations to create integrated systems that enable the manufacturer and physician to deliver a clear and concise message directly to the patient. ; Their flagship product, 3D-Eye Office, provides a full library of eye related 3D animations driven through PC based software systems. ; Visit http://www.eyemaginations.com or call 877-321-5481 for more information about Eyemaginations.


;


About NearVision CK


NearVision CK is performed using a probe thinner than a strand of hair that releases radiofrequency energy. ; Applied to the cornea in a circular pattern, the radio waves shrink small areas of collagen to create a constrictive band (like the tightening of a belt) that increases the curvature of the cornea, bringing near vision back into focus. NearVision CK is indicated for the temporary improvement of near vision in emmetropic presbyopes (those who require only reading glasses) and hyperopic presbyopes (those who require reading and distance glasses).


;


About Refractec


Refractec, Inc. is a privately held ophthalmic technology company that develops and markets minimally invasive treatments for ophthalmologists and their baby boomer patients. ; Based in Irvine, Calif., Refractec provides « Corrective Solutions for Near Vision » with its proprietary NearVision CK (Conductive Keratoplasty) technology. Patients can visit (http://www.myclearvision.com) or call 1-800-752-9544 for more information on NearVision CK and to obtain a list of physicians.


;


;


SOURCE Refractec, Inc.
Web Site: http://www.refractec.com http://www.eyemaginations.com
http://www.myclearvision.com


;



All of the above text is a press release provided by the quoted organization. globalagingtimes.com accepts no responsibility for their accuracy.


Partager cet article

Laisser un commentaire